Concepedia

T Szamosi

TS

Statistics

Publications

9

Citations

395

H-Index

9

Active since

2008

Affiliations

Semmelweis University(Current)

University of Szeged

University of Pecs

University of Debrecen

Markusovszky Egyetemi Oktatókórház

T Szamosi is an author at Semmelweis University specializing in inflammatory bowel disease, inflammatory disease pharmacotherapy, and crohn disease pharmacotherapy.

Publications per year

2008–2023

9

Publications

9

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh et al. · New England Journal of Medicine · 2020 · 190 citations · Full text

, , +17

ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients

Péter L. Lakatos, T Szamosi, Anikó Szilvási et al. · Digestive and Liver Disease · 2008 · 62 citations · Full text

, , +11

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Lóránt Gönczi, K Gecse, Zsuzsanna Végh et al. · Inflammatory Bowel Diseases · 2017 · 57 citations · Full text

, , +16

Interaction between seroreactivity to microbial antigens and genetics in Crohn’s disease: is there a role for defensins?

Péter L. Lakatos, I Altorjay, Yvette Mándi et al. · Tissue Antigens · 2008 · 20 citations

, , +17

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study

Tamás Resál, Péter Bacsúr, Csilla Keresztes et al. · Inflammatory Bowel Diseases · 2023 · 15 citations · Full text

, , +14

1–5 of 9